481 related articles for article (PubMed ID: 11697820)
1. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
3. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
4. Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds.
Okazaki T; Kato Y; Mochizuki T; Tashima M; Sawada H; Uchino H
Exp Hematol; 1988 Jan; 16(1):42-8. PubMed ID: 2826200
[TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps.
Kim SH; Kim TS
Planta Med; 2002 Oct; 68(10):886-90. PubMed ID: 12391550
[TBL] [Abstract][Full Text] [Related]
6. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
Makishima M; Kanatani Y; Yamamoto-Yamaguchi Y; Honma Y
Blood; 1996 Apr; 87(8):3384-94. PubMed ID: 8605356
[TBL] [Abstract][Full Text] [Related]
8. Synergistic stimulatory effect of 12-O-tetradecanoylphorbol-13-acetate and capsaicin on macrophage differentiation in HL-60 and HL-525 human myeloid leukemia cells.
Zheng X; Ryan A; Patel N; Klemons S; Hansson A; Shih WJ; Lin Y; Huberman E; Chang RL; Conney AH
Int J Oncol; 2005 Feb; 26(2):441-8. PubMed ID: 15645129
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60.
Zylber-Katz E; Glazer RI
Cancer Res; 1985 Oct; 45(10):5159-64. PubMed ID: 3161611
[TBL] [Abstract][Full Text] [Related]
10. Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines.
Defacque H; Dornand J; Commes T; Cabane S; Sevilla C; Marti J
J Pharmacol Exp Ther; 1994 Oct; 271(1):193-9. PubMed ID: 7965714
[TBL] [Abstract][Full Text] [Related]
11. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phorbol ester-induced phenotypic differentiation of HL-60 cells by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a protein kinase inhibitor.
Matsui T; Nakao Y; Koizumi T; Katakami Y; Fujita T
Cancer Res; 1986 Feb; 46(2):583-7. PubMed ID: 3606750
[TBL] [Abstract][Full Text] [Related]
13. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
[TBL] [Abstract][Full Text] [Related]
14. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
16. Role of intracellular calcium ion in human promyelocytic leukemia HL-60 cell differentiation.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
Cancer Res; 1986 Dec; 46(12 Pt 1):6059-63. PubMed ID: 3465433
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-associated changes in the expression of chondroitin sulfate proteoglycan in induced U-937 cells.
Kolset SO; Ivhed I; Overvatn A; Nilsson K
Cancer Res; 1988 Nov; 48(21):6103-8. PubMed ID: 2844400
[TBL] [Abstract][Full Text] [Related]
18. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
19. Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of HL-60 leukemia cells.
Kim SH; Kim SW; Choi SJ; Kim YC; Kim TS
Bioorg Med Chem; 2006 Oct; 14(19):6752-8. PubMed ID: 16765600
[TBL] [Abstract][Full Text] [Related]
20. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]